These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6990883)

  • 1. The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei.
    Merkli B; Richle R; Peters W
    Ann Trop Med Parasitol; 1980 Feb; 74(1):1-9. PubMed ID: 6990883
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490).
    Peters W; Portus J; Robinson BL
    Ann Trop Med Parasitol; 1977 Dec; 71(4):419-27. PubMed ID: 339857
    [No Abstract]   [Full Text] [Related]  

  • 3. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei.
    Kazim M; Puri SK; Dutta GP
    Indian J Med Res; 1979 Dec; 70 Suppl():95-102. PubMed ID: 121298
    [No Abstract]   [Full Text] [Related]  

  • 5. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
    Tan-Ariya P; Brockelman CR; Menabandhu C
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
    Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
    Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490).
    Peters W; Howells RE; Portus J; Robinson BL; Thomas S; Warhurst DC
    Ann Trop Med Parasitol; 1977 Dec; 71(4):407-18. PubMed ID: 339856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of Plasmodium yoelii nigeriensis resistant to triple drug combination (sulphadoxine/pyrimethamine/mefloquine) and its response to other antimalarials.
    Shukla B; Bajpai R; Dutta GP
    Indian J Malariol; 1988 Jun; 25(1):1-6. PubMed ID: 3266603
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine.
    Fitch CD; Chan RL; Chevli R
    Antimicrob Agents Chemother; 1979 Feb; 15(2):258-62. PubMed ID: 371544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delay in emergence of resistance to pyronaridine phosphate in Plasmodium berghei].
    Shao BR; Ye XY
    Zhongguo Yao Li Xue Bao; 1986 Sep; 7(5):463-7. PubMed ID: 2954424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitory effect of artemisinine-sulfadoxine-pyrimethamine combination on the development of drug-resistance in Plasmodium berghei].
    Zhou YQ; Ning DX
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):453-7. PubMed ID: 3064550
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmodium berghei: phase contrast and electron microscopical evidence that certain antimalarials can both inhibit and reverse pigment clumping caused by chloroquine.
    Einheber A; Palmer DM; Aikawa M
    Exp Parasitol; 1976 Aug; 40(1):52-61. PubMed ID: 780119
    [No Abstract]   [Full Text] [Related]  

  • 13. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
    Burchard GD; Winkler E
    Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of infectivity for Swiss mice of a mefloquine-resistant strain of plasmodium berghei.
    Puri SK; Kazim M; Dutta GP
    Trans R Soc Trop Med Hyg; 1982; 76(5):650-1. PubMed ID: 6758223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Glutathione Biosynthesis Sensitizes Plasmodium berghei to Antifolates.
    Songsungthong W; Koonyosying P; Uthaipibull C; Kamchonwongpaisan S
    Antimicrob Agents Chemother; 2016 May; 60(5):3057-64. PubMed ID: 26953195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
    Espinal CA; Cortes GT; Guerra P; Arias AE
    Am J Trop Med Hyg; 1985 Jul; 34(4):675-80. PubMed ID: 3895999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
    Ghosh SK; Yadav RS; Sharma VP
    Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
    Goldring JD; Padayachee T; Ismail I
    Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.